PWUPU
Market cap | $96.37 Million |
---|---|
Enterprise Value | $98.16 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.23 |
Beta | 0 |
Outstanding Shares | 8,465,764 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -31.94 |
---|---|
PEG | -5.85 |
Price to Sales | - |
Price to Book Ratio | -11.93 |
Enterprise Value to Revenue | - |
Enterprise Value to EBIT | -9.34 |
Enterprise Value to Net Income | -4 |
Total Debt to Enterprise | 0.03 |
Debt to Equity | -0.45 |
No data
No data
Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge resear...